Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.
Wenfeng FangHaoxuan JinHua-Qiang ZhouShaodong HongYuxiang MaYaxiong ZhangXiaofan SuLongyun ChenYunpeng YangShengqiang XuYuwei LiaoYuming HeHongyun ZhaoYan HuangZhibo GaoLi ZhangPublished in: Molecular cancer (2021)
Keyphrases